|
|||||
|
|
A phase II study of brentuximab vedotin in patients with relapsed or refractory Epstein-Barr virus-positive and CD30-positive lymphomas |
|
| Authors: | Miso Kim Jeong-Ok Lee Jiwon Koh Tae Min Kim Ji Yun Lee Yoon Kyung Jeon Bhumsuk Keam Dong-Wan Kim Jong Seok Lee Dae Seog Heo |
| Affiliation: | 1.Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea;2.Seoul National University Cancer Research Institute, Seoul, Republic of Korea;3.Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea;4.Department of Pathology, Seoul National University Hospital, Seoul, Republic of Korea |
| Abstract: | |
| Keywords: | |